Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-157-9 | CAS number: 12676-29-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V.
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 20.8 +/- 1.1
- Housing: Group
- Diet (e.g. ad libitum): Pelleted standard diet, ad libitum
- Water (e.g. ad libitum): Tap water, ad libitum
- Acclimation period: At least 5 days prior to the start of dosing
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 + 2°C
- Humidity (%): 30 – 65% (acclimation period)
45 – 65% (pre-test and main study)
- Air changes (per hr): About 10 / hour
- Photoperiod (hrs dark / hrs light): 12/12
DEVIATIONS:
During the acclimation period for animals used for this study the relative humidity in the animal room ranged between 30 – 65 % instead of 45 – 65% for a few hours. This deviation to the study plan, however, did not affect the validity of the study. - Vehicle:
- propylene glycol
- Concentration:
- 5, 10, and 25%
- No. of animals per dose:
- Number of animals for the pre-test: 2 females
Number of animals for the main study: 20 females
Number of animals per group: 5 females (nulliparous and non-pregnant) - Details on study design:
- A solubility experiment was performed according to the recommendations given by OECD 429. The highest test item concentration, which could be technically used was a 25% (w/w) suspension in propylene glycol. Vortexing and sonicating and, if required, warming to 37°C, were used to formulate the test item. At higher concentrations, an applicable formulation of the test item was not achieved, neither by the use of other vehicles nor by using additional methods to formulate the test item.
To determine the highest non-irritant test concentration that does not induce signs of systemic toxicity at the same time, a pre-test was performed in two animals. Two mice were treated by topical application to the dorsal surface of each ear with test item concentrations of 10% and 25% (w/w) once daily each on three consecutive days. - Positive control substance(s):
- other: alpha-hexyl cinnamaldehyde dissolved in acetone:olive oil (4:1 v/v)
- Statistics:
- A statistical analysis was conducted on the DPM values, the ear weights, the lymph node weights and the lymph node cell count to assess whether the difference was statistically significant between test item groups and negative control group. For all statistical calculations SigmaStat for Windows (Version 2.0) was used. A One-Way-Analysis-of-Variance was used as statistical method. In case of significant results of the One-Way-ANOVA, multiple comparisons were performed with the Dunnett test. Statistical significance was set at the five per cent level (p < 0.05). The Dean-Dixon-Test was used for identification of possible outliers (performed with Microsoft Excel 2003). Outliers were not identified.
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- In this study Stimulation Indices (S.I.) of 1.45, 1.53, and 2.58 were determined with the test item at concentrations of 5, 10, and 25% (w/w) in propylene glycol, respectively. A statistically significant increase in DPM value was obtained in the high dose group in comparison to the vehicle control group (p<0.05) and a dose response was observed. However, none of the obtained S.I.s exceeded the threshold value of 3 for a positive response.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: A statistically significant increase in DPM value was obtained in the high dose group in comparison to the vehicle control group (p<0.05) and a dose response was observed.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- A statistically significant increase in lymph node cell count was observed in the highest dose group in comparison to the vehicle control group. Still, the cutoff-value of 1.55 for a positive response regarding the lymph node cell count index reported for BALB/c mice was not exceeded in any test item treated group. The lymph node weight did not show a statistically significant increase in comparison to the control group.
The test item Silicone boride oxide was not a skin sensitiser under the test conditions of this study.
Reference
Test item concentration |
Group calculation |
||
Mean DPM per animal |
SD |
S.I. |
|
Vehicle (propylene glycol) |
453.9 |
228.7 |
1.00 |
5% Silicone boride oxide |
657.1 |
332.7 |
1.45 |
10% Silicon boride oxide |
692.9 |
111.2 |
1.53 |
25% Silicon boride oxide |
1169.3* |
292.1 |
2.58 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
A LLNA was performed with concentrations of 5, 10, and 25% of silicone boride oxide.
A statistically significant increase in DPM value was obtained in the high dose group in comparison to the vehicle control group (p<0.05) and a dose response was observed. However, none of the obtained S.I.s exceeded the threshold value of 3 for a positive response.
A statistically significant increase in lymph node cell count was observed in the highest dose group in comparison to the vehicle control group. Still, the cutoff-value of 1.55 for a positive response regarding the lymph node cell count index reported for BALB/c mice was not exceeded in any test item treated group. The lymph node weight did not show a statistically significant increase in comparison to the control group.
The test item Silicone boride oxide was not a skin sensitiser under the test conditions of this study.
Migrated from Short description of key information:
5%, 10%, 25% test substance led to S.I. of 1.45, 1.53, and 2.58, respectively.
Justification for selection of skin sensitisation endpoint:
Guideline- and GLP study
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the data available, silicon boride oxide does not fulfill the criteria for classification according to EC 1272/2008 (CLP). Therefore, non-classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.